Global COVID-19 Antibody and Serology Tests Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global COVID-19 Antibody and Serology Tests Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

An antibody or serology test is a blood test that looks for signs of a previous COVID-19 infection. It detects antibodies, which are proteins in the blood that fight off infection. Antibody testing has a lot of promise because it will help understand the pervasiveness of COVID-19 in communities. Antibodies are developed by the body in response to an infection or after vaccination. SARS-CoV-2 is the virus that causes COVID-19. SARS-CoV-2 antibody tests detect antibodies to the SARS-CoV-2 virus.

Market Overview:

The latest research study on the global COVID-19 Antibody and Serology Tests market finds that the global COVID-19 Antibody and Serology Tests market reached a value of USD 1184.66 million in 2022. It’s expected that the market will achieve USD 234.48 million by 2028, exhibiting a CAGR of -23.66% during the forecast period.

Opportunities and Drivers

Antibody test kits predict the prognosis of COVID-19 infection and detect to assist the disease. Since these kits help to check whether a person's blood has produced antibodies against SARS-CoV-2, it can indicate whether a person has been exposed to or has COVID-19. To manage the COVID-19 pandemic and increase patient screening, several companies are making these rapid antibody test kits available to healthcare workers, hospitals, laboratories and other professionals. Hence, rising incidence of coronavirus cases and increasing government approval of antibody testing kits are few factors contributing to the market growth.
Antibody testing can identify previously infected individuals who are asymptomatic. This information is essential for guiding transmission control measures such as quarantine, isolation, and social distancing, as well as the closure of schools, places of worship, and businesses. Another benefit of antibody testing is that it can aid in vaccine development and efficacy. The testing can identify which parts of the virus the immune system responds to and should be targeted during vaccine development. Results can be obtained in less time using COVID-19 antibody and serology tests. After the virus invades the human body, the human body will produce IgM or IgG antibodies for defense, and serological testing is to indirectly determine whether there is virus or virus infection in the body by detecting the presence and content of IgM and IgG in blood samples. Therefore, the combined use of nucleic acid detection and serum antibody detection can help to improve the disease detection rate.

Region Overview:

From 2022-2027, North America is estimated to witness robust growth prospects.

Company Overview:

The top three companies Siemens Healthcare Diagnostics, Abbott Laboratories, Beckman Coulter with the revenue market share of 13.12%, 13.64%, 15.22%in 2022.

Siemens Healthcare Diagnostics Inc. provides clinical diagnostic services and therapeutic systems. On May 4th, 2016, Siemens Healthcare unveiled its new name Siemens Healthineers. Siemens Healthineers will continue to strengthen its leading portfolio across the medical imaging and laboratory diagnostics business, and complementing it with new offerings such as management‐, consulting‐, and digital services, and further technologies in the growing therapeutic and molecular diagnostics market.

Abbott Laboratories is an American multinational medical devices and health care company with headquarters in Abbott Park, Illinois, United States. The company was founded by Chicago physician Wallace Calvin Abbott in 1888 to formulate known drugs; today, it sells medical devices, diagnostics, branded generic medicines and nutritional products. It split off its research-based pharmaceuticals business into AbbVie in 2013.

Segmentation Overview:

By type, Lateral Flow segment accounted for the largest share of market in 2021.

Application Overview:

By application, the Hospitals segment occupied the biggest share from 2017 to 2022.

Key Companies in the global COVID-19 Antibody and Serology Tests market covered in Chapter 3:

Mount Sinai Hospital Clinical Laboratory
Emory Medical Laboratories
DiaSorin
Wadsworth Center
Cellex
Roche
Wuhan Easy Diagnosis Biomedicine
Diazyme Laboratories
HANGZHOU ALLTEST BIOTECH
ADVAITE
Dynamiker Biotechnology (Tianjin)
Zhejiang Orient Gene Biotech
Vazyme
EUROIMMUN
Abbott Laboratories
Vibrant America Clinical Labs
Access Bio
bioMérieux
Ortho-Clinical Diagnostics
InBios International
Luminex Corporation
BioMedomics
Megna Health
Beckman Coulter
Siemens Healthcare Diagnostics
Bio-Rad Laboratories

In Chapter 4 and Chapter 14.2, on the basis of types, the COVID-19 Antibody and Serology Tests market from 2018 to 2029 is primarily split into:

High Throughput CMIA
Lateral Flow
ELISA
ELFA
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the COVID-19 Antibody and Serology Tests market from 2018 to 2029 covers:

Hospitals
Clinics
Academic and Research Center
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)